
Overview:
ProductName | CytochalasinD |
Description | Actinpolymerizationinhibitor |
Purity | >98%(TLC);NMR(Conforms) |
CASNo. | 22144-77-0 |
MolecularFormula | C30H37NO6 |
MolecularWeight | 507.63 |
Properties
StorageTemperature | -20ºC |
ShippingTemperature | ShippedAmbient |
ProductType | Inhibitor |
Solubility | Solubleto10mMinethanolandto50mMinDMSO |
Source | Synthetic |
Appearance | WhiteSolid |
SMILES | C[[email protected]]1C/C=C/[[email protected]]2[[email protected]@H](C(=C)[[email protected]]([[email protected]@H]3[[email protected]@]2([[email protected]@H](/C=C/[[email protected]](C1)C)OC(=O)C)C(=O)N[[email protected]]3CC4=CC=CC=C4)C)O |
InChI | InChI=1S/C30H37NO6/c1-17-10-9-13-22-26(33)19(3)18(2)25-23(16-21-11-7-6-8-12-21)31-28(35)30(22,25)24(37-20(4)32)14-15-29(5,3 |
InChIKey | SDZRWUKZFQQKKV-BBXOWAOSSA-N |
SafetyPhrases | Classification:Toxic.Maybeharmfulorfatalifinhaled,swallowedorabsorbedthroughskin.SafetyPhrases:S22-DonotbreathedustS24/25-AvoidcontactwithskinandeyesS36/37/39-Wearsuitableprotectiveclothing,glovesandeye/faceprotectionRiskPhrases:R62-PossIBLeriskofimpairedfertilityR68-PossibleriskofirreversibleeffectsHazardPhrases:H300-H361PrecautionaryPhrases:P264-P281-P301+P310 |
CiteThisProduct | CytochalasinD(StressMarqBiosciencesInc.,VictoriaBCCANADA,Catalog#SIH-241) |
BIOLOGicalDescription
AlternativeNames | (3S,3aR,4S,6S,6aR,7E,10S,12S,13E,15R,15aR)-3-Benzyl-6-hydroxy-4,10,12-trimethyl-5-methylene-1-oxo-2,3,3a,4,5,6,6a,9,10,11,12,15-dodecahydro-1H-cycloundeca[d]isoindol-15-ylacetate,ZygosporinA |
ResearchAreas | Cancer,Apoptosis |
PubChemID | 5458428 |
ScientificBackground | CytochalasinshavetheABIlitytobindtoactinfilamentsandblockpolymerizationandelongationofactin.Asaresult,theycanchangecellularmorphology,inhibitcellularprocessesandcausecellstoundergoapoptosis(1).CytochalasinDinparticularcaninhibitproteinsynthesis(2). |
References | 1. HaidleA.,andMyersA.(2004)ProcNatlAcadSci.101(33):12048-12053. 2.Ornellesetal.,(1986)MolCellBiol.6(5):1650-1662. |
ProductImages

ChemicalstructureofCytochalasinD(SIH-241),aDisruptsactinfilaments.CAS#:22144-77-0.MolecularFormula:C30H37NO6.MolecularWeight:507.63g/mol.
ProductCitations(3)
OtherCitations
M2BPinhibitsHIV-1virionproductioninavimentinfilaments-dependentmanner.
Wang,Q.,Zhang,X.,Han,Y.,Wang,X.andGao,G.(2016)SciRep.6:32736.
PubMedID:27604950Applications:Celltreatment
PlasmacontributestotheantimicrobialactivityofwholebloodagainstMycobacteriumtuberculosis.
López-Medrano,R.(2016)InnateImmun.22(7):557-66.
PubMedID:27554054Applications:Invitroinhibition
BlebformationisinducedbyalkalinebutnotacidicpHinestrogenreceptorsilencedbreastcancercells.
Khajah,M.A.,Mathew,P.M.,Alam-Eldin,N.S.andLuqmani,Y.A.(2015)IntJOncol.46(4):1685-98.
PubMedID:25672508Applications:Invitroinhibition
ebiomall.com






>
>
>
>
>
>
>
>
>
>
>
>
TAE是使用最广泛的缓冲系统。其特点是超螺旋在其中电泳时更符合实际相对分子质量(TBE中电泳时测出的相对分子质量会大于实际分子质量),且双链线状DNA在其中的迁移率较其他两种缓冲液快约10%,电泳大于13kb的片段时用TAE缓冲液将取得更好的分离效果,此外,回收DNA片段时也易用TAE缓冲系统进行电泳。TAE的缺点是缓冲容量小,长时间电泳(如过夜)不可选用,除非有循环装置使两极的缓冲液得到交换。 50×TAE Buffer 配制方法: 1. 称量Tris 242g,Na2EDTA.2H2O 37.2g 于1L烧杯中; 2.向烧杯中加入约800ml去离子水,充分搅拌均匀; 3加入57.1ml的冰乙酸,充分溶解; 4.加去离子水定容至1L后,室温保存。向左转|向右转
1. Buffer中离子浓度过大,甘氨酸或者Tris碱有可能疏忽多加了
2.没有加相应浓度的SDS
3.电泳周围温度高,也是一个原因
此外,我们常常用“电泳法”判断液体的性质,是胶体还是溶液。在高中化学中我们就用过这种方法判断给定的液体是否为胶体。MOPS电泳缓冲液、胚胎干细胞培养生长因子、动物肝细胞分离培养试剂盒、结晶紫细胞群落染色试剂盒、MFN-2蛋白表达检测试剂盒、血红细胞溶解液、磷酸缓冲盐溶液、Hanks平衡盐粉剂、胰蛋白酶溶液、
低离子强度时,迁移率快。但离子强度过低,缓冲液的缓冲容量小,不易维持pH恒定。高离子强度时迁移率慢,因此为了获得更快的反应速度,在缓冲容量允许的范围内,离子强度应该尽可能小。

